Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel.
Buttigliero C, Tucci M, Vignani F, Di Stefano RF, Leone G, Zichi C, Pignataro D, Lacidogna G, Guglielmini P, Numico G, Scagliotti GV, Di Maio M. Buttigliero C, et al. Among authors: lacidogna g. Clin Genitourin Cancer. 2018 Aug;16(4):318-324. doi: 10.1016/j.clgc.2018.05.006. Epub 2018 Jun 1. Clin Genitourin Cancer. 2018. PMID: 29866495
The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life.
Baratelli C, Turco CGC, Lacidogna G, Sperti E, Vignani F, Marino D, Zichi C, De Luca E, Audisio M, Ballaminut D, Bellezza A, Chiotto P, Ciriolo G, Comite R, Codegone F, Florio S, Fusco L, Polimeno L, Pozzi D, Zilio E, Terzolo S, Di Maio M. Baratelli C, et al. Among authors: lacidogna g. Support Care Cancer. 2019 Dec;27(12):4697-4704. doi: 10.1007/s00520-019-04777-2. Epub 2019 Apr 4. Support Care Cancer. 2019. PMID: 30949832
Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide.
Buttigliero C, Tucci M, Sonetto C, Vignani F, Di Stefano RF, Pisano C, Turco F, Lacidogna G, Guglielmini P, Numico G, Scagliotti GV, Di Maio M. Buttigliero C, et al. Among authors: lacidogna g. Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10. Minerva Urol Nefrol. 2020. PMID: 32284527 Free article.
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
Bersanelli M, Giannarelli D, De Giorgi U, Pignata S, Di Maio M, Verzoni E, Clemente A, Guadalupi V, Signorelli D, Tiseo M, Giusti R, Filetti M, Di Napoli M, Calvetti L, Cappetta A, Ermacora P, Zara D, Barbieri F, Baldessari C, Scotti V, Mazzoni F, Veccia A, Guglielmini PF, Maruzzo M, Rossi E, Grossi F, Casadei C, Cortellini A, Verderame F, Montesarchio V, Rizzo M, Mencoboni M, Zustovich F, Fratino L, Cinieri S, Negrini G, Banzi M, Sorarù M, Zucali PA, Lacidogna G, Russo A, Battelli N, Fornarini G, Mucciarini C, Bracarda S, Bonetti A, Pezzuolo D, Longo L, Sartori D, Iannopollo M, Cavanna L, Meriggi F, Tassinari D, Corbo C, Gernone A, Prati V, Carnio S, Giordano P, Dicorato AM, Verusio C, Atzori F, Carrozza F, Gori S, Castro A, Pilotto S, Vaccaro V, Garzoli E, Di Costanzo F, Maiello E, Labianca R, Pinto C, Tognetto M, Buti S. Bersanelli M, et al. Among authors: lacidogna g. Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33224275 Free PMC article.
Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients.
Marino D, Baratelli C, Guida G, Turco CGC, Lacidogna G, Sperti E, Vignani F, De Luca E, Zichi C, Audisio M, Ballaminut D, Bellezza A, Chiotto P, Ciriolo G, Comite R, Codegone F, Florio S, Fusco L, Polimeno L, Pozzi D, Zilio E, Terzolo S, Di Maio M. Marino D, et al. Among authors: lacidogna g. Recenti Prog Med. 2020 Dec;111(12):740-748. doi: 10.1701/3509.34965. Recenti Prog Med. 2020. PMID: 33362171
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
Bersanelli M, Verzoni E, Cortellini A, Giusti R, Calvetti L, Ermacora P, Di Napoli M, Catino A, Guadalupi V, Guaitoli G, Scotti V, Mazzoni F, Veccia A, Guglielmini PF, Perrone F, Maruzzo M, Rossi E, Casadei C, Montesarchio V, Grossi F, Rizzo M, Travagliato Liboria MG, Mencoboni M, Zustovich F, Fratino L, Accettura C, Cinieri S, Camerini A, Sorarù M, Zucali PA, Ricciardi S, Russo A, Negrini G, Banzi MC, Lacidogna G, Fornarini G, Laera L, Mucciarini C, Santoni M, Mosillo C, Bonetti A, Longo L, Sartori D, Baldini E, Guida M, Iannopollo M, Bordonaro R, Morelli MF, Tagliaferri P, Spada M, Ceribelli A, Silva RR, Nolè F, Beretta G, Giovanis P, Santini D, Luzi Fedeli S, Nanni O, Maiello E, Labianca R, Pinto C, Clemente A, Tognetto M, De Giorgi U, Pignata S, Di Maio M, Buti S, Giannarelli D; FICOG group (Federation of Italian Cooperative Oncology Groups). Bersanelli M, et al. Among authors: lacidogna g. EClinicalMedicine. 2023 Jun 29;61:102044. doi: 10.1016/j.eclinm.2023.102044. eCollection 2023 Jul. EClinicalMedicine. 2023. PMID: 37434748 Free PMC article.
Possible clinical and radiological predictors of haemorrhagic transformation in acute stroke patients undergoing dual antiplatelet therapy: a clinical study.
Bagnato MR, Maestrini I, Bruno L, Ciullo I, D'Agostino F, Lacidogna G, Marrama F, Mascolo AP, Rocco A, Diomedi M. Bagnato MR, et al. Among authors: lacidogna g. Ther Adv Neurol Disord. 2024 Oct 21;17:17562864241289735. doi: 10.1177/17562864241289735. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 39445085 Free PMC article.
Safety and efficacy of bridging intravenous thrombolysis plus mechanical thrombectomy versus direct mechanical thrombectomy in different age groups of acute ischemic stroke patients.
Marrama F, Mascolo AP, Sallustio F, Bovino M, Rocco A, D'Agostino F, Ros VD, Morosetti D, Mori F, Lacidogna G, Maestrini I, Alemseged F, Panetta V, Diomedi M. Marrama F, et al. Among authors: lacidogna g. Acta Neurol Belg. 2024 Oct 22. doi: 10.1007/s13760-024-02672-0. Online ahead of print. Acta Neurol Belg. 2024. PMID: 39436555
Outcomes and safety of endovascular treatment from 6 to 24 hours in patients with a pre-stroke moderate disability (mRS 3): a multicenter retrospective study.
Maestrini I, Rocchi L, Diana F, Requena Ruiz M, Elosua-Bayes I, Ribo M, Abdalkader M, Klein P, Gabrieli JD, Alexandre AM, Pedicelli A, Lacidogna G, Ciullo I, Marnat G, Cester G, Broccolini A, Nguyen TN, Tomasello A, Garaci F, Diomedi M, Da Ros V. Maestrini I, et al. Among authors: lacidogna g. J Neurointerv Surg. 2024 May 29:jnis-2024-021634. doi: 10.1136/jnis-2024-021634. Online ahead of print. J Neurointerv Surg. 2024. PMID: 38811146
48 results